NEW YORK, April 4, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding
Weingarten Realty Investors (NYSE: WRI), Liberty Property Trust
(NYSE: LPT), BioMed Realty Trust Inc. (NYSE: BMR), Taubman Centers
Inc. (NYSE: TCO), and CommonWealth REIT (NYSE: CWH). Private wealth
members receive these notes ahead of publication. To reserve
complementary membership, limited openings are available at:
http://www.AnalystsReview.com/register
--
Weingarten Realty Investors Analyst Notes
On April 1, 2014, Weingarten
Realty Investors (Weingarten Realty) stock increased 1.30%, ending
the day at $30.39. Over the previous
five trading sessions, shares of Weingarten Realty increased 2.22%
compared to the Dow Jones Industrial Average which also increased
1.01% during the same period. The full analyst notes on Weingarten
Realty Investors are available to download free of charge at:
http://www.AnalystsReview.com/04042014/WRI/report.pdf
--
Liberty Property Trust Analyst Notes
On April 1, 2014, Liberty Property
Trust (Liberty Property) stock increased 0.54%, ending the day at
$37.16. For the past month, shares of
Liberty Property declined 2.87%, compared to the Dow Jones
Industrial Average which increased 1.29% during the same period.
The full analyst notes on Liberty Property Trust are available to
download free of charge at:
http://www.AnalystsReview.com/04042014/LPT/report.pdf
--
BioMed Realty Trust Inc. Analyst Notes
On March 31, 2014, BioMed Realty
Trust Inc. (BioMed Realty) reported that the Company's rating
outlook on its investment grade corporate credit rating from
Moody's Investors Service was revised to positive from stable.
Greg N. Lubushkin, Chief Financial
Officer of BioMed Realty, commented, "We are very pleased with the
positive outlook from Moody's which reflects the sustained,
systematic enhancement of our credit quality since we became the
first life science real estate investment trust to receive an
investment grade corporate credit rating in 2010. In addition, the
recent Moody's and S&P actions validate our steady approach to
growing our industry-leading portfolio, as well as our proven track
record of executing a sound, long-term capital strategy which
enables us to better serve the life science communities in
the United States and United Kingdom." The full analyst notes on
BioMed Realty Trust Inc. are available to download free of charge
at:
http://www.AnalystsReview.com/04042014/BMR/report.pdf
--
Taubman Centers Inc. Analyst Notes
On March 21, 2014, Taubman Centers
Inc. (Taubman) declared that it will release its Q1 2014 earnings
after the market closing on April 24,
2014. Taubman will also hold a conference call to review the
results on April 25, 2014 at
11:00 a.m. EDT. Interested parties
can access a live broadcast of the conference call online at the
Investor section of the Company website, where an online replay
will also be available for at least 90 days. The full analyst notes
on Taubman Centers Inc. are available to download free of charge
at:
http://www.AnalystsReview.com/04042014/TCO/report.pdf
--
CommonWealth REIT Analyst Notes
On March 25, 2014, CommonWealth
REIT reported that it confirmed that Related Fund Management LLC
and Corvex Management LP delivered to CWH written consents reaching
the 66.7% threshold necessitated the removal of remove the entire
CWH Board of Trustees, without cause, and all CWH Trustees have
been removed. In accordance with the November 18, 2013 Arbitration Panel order and
CWH's Declaration of Trust, the officers of CWH will immediately
call a special meeting of shareholders in order to elect new
Trustees to the CWH Board. The Company will file a preliminary
information statement for the special meeting with the Securities
& Exchange Commission (SEC) within one week as required by
federal securities laws. The Company shall hold the special meeting
on or before Friday, May 23, 2014,
subject to the timely completion of the required SEC regulatory
review of the information statement. CWH will declare the time,
date and place of the special meeting and the record date therefor
concurrently with filing the definitive information statement with
the SEC. The full analyst notes on CommonWealth REIT are available
to download free of charge at:
http://www.AnalystsReview.com/04042014/CWH/report.pdf
--
About Analysts Review
We provide our members with a simple and reliable way to leverage
our economy of scale. Most investors do not have time to track all
publicly traded companies, much less perform an in-depth review and
analysis of the complexities contained in each situation. That's
where Analysts Review comes in. We provide a single unified
platform for investors' to hear about what matters. Situation
alerts, moving events, and upcoming opportunities.
--
=============
EDITOR NOTES:
- This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
- This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
- If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] AnalystsReview.com.
- For any urgent concerns or inquiries, please contact us
at compliance [at] AnalystsReview.com.
- Are you a public company? Would you like to see similar
coverage on your company? Send us a full investors' package to
research [at] AnalystsReview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort
basis. This document, article or report is prepared and authored by
Analysts Review. An outsourced research services provider
represented by Nidhi Vatsal, CFA, has only reviewed the information
provided by Analysts Review in this article or report according to
the Procedures outlined by Analysts Review. Analysts Review is not
entitled to veto or interfere in the application of such procedures
by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to
the accuracy or completeness or fitness for a purpose (investment
or otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Analysts Review
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Analysts Review expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Analysts Review does not (1)
guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
AnalystsReview.com
SOURCE Analysts Review